Researchers identify increase in serious neurological disorder cases following AstraZeneca vaccine Ruchika Sharma3 Jun 2022 3:23 PM ISTGuillain-Barre syndrome (GBS) is a rare but serious autoimmune condition that attacks the peripheral nervous system, typically resulting in numbness,...
AstraZeneca gets CDSCO nod to conduct Phase III CT of antineoplastic FDCs drug Dr. Divya Colin24 May 2022 10:45 AM ISTNew Delhi: Suggesting to increase the number of subjects in clinical trial to 34, from the proposed 24 subjects in India, the Subject Expert Committee...
Coronavirus: India supplies non-JnJ vaccine under Quad umbrella Ruchika Sharma21 May 2022 10:00 AM ISTBagchi did not give numbers, but Indian foreign ministry data shows that India last month sent 200,000 doses of Covovax, a version of the Novavax...
AstraZeneca, RQ Biotechnology ink pact for monoclonal antibodies against coronavirus Ruchika Sharma18 May 2022 2:36 PM ISTUnder the agreement, AstraZeneca has acquired an exclusive worldwide licence to develop, manufacture and commercialise mAbs against SARS-CoV-2.
AstraZeneca booster effective against severe COVID: UK study Ruchika Sharma7 May 2022 10:00 AM ISTThe research supports the use of the AstraZeneca booster for protection against severe disease with COVID-19 in settings that have not yet offered...
AstraZeneca, Daiichi Sankyo get USFDA nod for Enhertu for earlier breast cancer use Ruchika Sharma6 May 2022 5:08 PM ISTThe approval was granted under the FDA's Real-Time Oncology Review (RTOR) programme and converts the accelerated approval of Enhertu in later line...
GSK, SK bioscience seek nod for SKYCovione in South Korea Ruchika Sharma1 May 2022 9:00 AM ISTSKYCovione is a self-assembled nanoparticle vaccine candidate targeting the receptor binding domain of the SARS-CoV-2 Spike protein for the parental...
Setback: AstraZeneca proposal to market, manufacture Olaparib rejected by CDSCO panel Dr. Divya Colin23 April 2022 5:03 PM ISTNew Delhi: In a major setback to AstraZeneca, the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO) has...
AstraZeneca India rebrands Global Technology Centre as Global Innovation and Technology Centre Ruchika Sharma8 April 2022 1:05 PM ISTThe rebranding marks the centre's evolution of capabilities, commitment to driving innovation and moving the company towards a digitally-enabled...
MoS Health Tells Rajya Sabha :Increase in Antibodies Post Covaxin Booster Dose Medical Dialogues Bureau31 March 2022 4:40 PM ISTNew Delhi: An ICMR study to examine the effect of Covaxin's booster dose has shown an increase in the levels of antibodies against SARS-CoV-2,...
AstraZeneca Evusheld recommended for approval in EU for prevention of COVID Ruchika Sharma27 March 2022 9:30 AM ISTThe recommended dose of Evusheld in Europe is 150 mg of tixagevimab and 150mg of cilgavimab, administered as two separate sequential intramuscular...
Bristol Myers sues AstraZeneca over cancer-treatment patents MD Bureau19 March 2022 6:08 PM ISTBristol asked the Delaware court for an undisclosed amount of monetary damages.
